Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...

It seems demand is growing amongst women in perimenopause, menopause and postmenopause looking for multifaceted weight loss ...

Semaglutide is a drug used for weight loss. Oral tablets and injections are both effective ways to take semaglutide. Oral tablets do not require the use of needles, but you may need to take them ...

A recent study published in Diabetes Technology & Therapeutics has demonstrated that the off-label use of semaglutide and ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

The company’s weight loss therapy was able to sustain itself for up to 40 days in obese patients after a single injection.

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Researchers analysed data from 150 adults with T1D, divided into semaglutide ... the potential of these therapies to complement insulin therapy and address critical unmet needs in T1D management.